decisionhealth Newsletters, Answer Books - 2008 Issue 5 (May)
National_Coverage_Determinations_Manual / GLYCATED_HEMOGLOBIN
Subscribe or sign in to view the full article.
Article Overview
This article summarizes national coverage guidance for glycated hemoglobin and glycated protein testing. It explains the general clinical purpose of these laboratory tests, who they are used for, and the broad categories of situations addressed by Medicare coverage policy, including routine diabetes monitoring, abnormal hemoglobin-related circumstances, and frequency limitations. It is useful for coders, billers, laboratory staff, and compliance professionals who need to understand the scope of covered testing under the National Coverage Determinations Manual.
Why This Topic Matters
Laboratory monitoring of diabetes is a common medical necessity issue, and this policy defines the general coverage framework for these tests. Understanding the article helps support compliant ordering, documentation, and claims handling.
What You Will Learn
- The general role of glycated hemoglobin and glycated protein testing in diabetes monitoring.
- The broad clinical situations addressed by national coverage guidance.
- The types of circumstances that may affect when alternative testing is considered.
- The overall focus of the policy on medical necessity and testing frequency.
Who Should Read This
- Medical coders
- Billing staff
- Clinical laboratory staff
- Compliance professionals
- Physician office staff
- Health information management professionals
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com